Abstract:[Background] The WNT/β-catenin signaling pathway is a major oncogenic pathway of human hepatocellular carcinoma (HCC). More than 50% of HCCs have aberrant activation of WNT/β-catenin signaling, which are caused by genetic alterations, ligand activation, or cross-activation by other signaling pathways. We hypothesized that activating mutation of CTNNB1, the coding gene of β-catenin, may confer sensitivity to WNT/β-catenin inhibitors in HCC cells. [Materials and Methods] SNU398 is a human HCC cell line harboring a missense somatic mutation in exon 3 of CTNNB1 gene, resulting in S37C mutation. Huh7, HepG2, PLC5, and Hep3B are HCC cells containing no somatic mutations in exon 3 of CTNNB1 gene. HCC cells were treated with various types of WNT/β-catenin pathway inhibitors, including ICG-001 which down-regulates β-catenin/TCF transcriptional activity by interfering the binding of β-catenin with its transcriptional activation complex, XAV939 which targets tankyrases and facilitates degradation of β-catenin, and LGK974 which inhibits Porcupine, an acyltransferase responsible for palmitoylation and secretion of Wnt ligands, and evaluated for in vitro viability by MTT. [Results] ICG-001 as a single agent showed significantly greater anti-proliferation effect in SNU398 than other HCC cells. The 50%-inhibitory concentrations (IC50s) of ICG-001 were 5 μM and >10 μM for SNU398 and other HCC cells, respectively. ICG-001 also induced a more potent suppression of colony- formation, and a more significant increase of subG1 fraction detected by flow cytometry in SNU398 cell than other HCC cells. XAV939 up to 20 μM induced only modest anti-proliferative effect in all HCC cells. However, SNU398 remained the one showing the greatest sensitivity to the growth suppression induced by XAV939. The anti-proliferative effect of LGK974 was modest and showed no significant difference among different HCC cells. [Conclusion] The activating mutation of β-catenin may confer sensitivity to certain WNT/β-catenin pathway inhibitors, such as ICG-001, in HCC cells. (This study was supported by grants NRPB-100CAP1020-2). Citation Format: Hsiao-Hui Lin, Wen-Chi Feng, LI-Chun Lu, Ta-Wen Hsu, Ann-Lii Cheng, Chih-Hung Hsu. Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2625. doi:10.1158/1538-7445.AM2014-2625

Expression of Wnt-5a and Β-Catenin in Primary Hepatocellular Carcinoma.

[Role of Wnt/β-catenin Signaling Pathway in Promoting Tumorigenesis of Hepatocellular Carcinoma].

Expression of Wnt-5a and Its Clinicopathological Significance in Hepatocellular Carcinoma

Expression of Wnt5a Gene in Human Hepatocellular Carcinoma and Its Clinical Significance

Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma

[Expression of Β-Catenin and HNF-1α and Their Influence on Prognosis in Human Hepatocellular Carcinoma].

Experimental Study of SerpinB5 and Β-Catenin in Primary Hepatocellular Carcinoma

Wnt Signaling in Hepatocellular Carcinoma: Analysis of Mutation and Expression of Beta-Catenin, T-cell Factor-4 and Glycogen Synthase Kinase 3-Beta Genes.

Mutation and Overexpression of the Β-Catenin Gene May Play an Important Role in Primary Hepatocellular Carcinoma among Chinese People

Abnormal Beta-Catenin Gene Expression with Invasiveness of Primary Hepatocellular Carcinoma in China

Increased Sensitivity To Wnt/Beta-Catenin Inhibitors In Hepatocellular Carcinoma Cells Harboring Activating Mutation Of Beta-Catenin

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Expression and clinical significance of GS,E-cadherin and β-catenin in hepatocellular carcinoma

Long Non-Coding RNA CASC15 is Upregulated in Hepatocellular Carcinoma and Facilitates Hepatocarcinogenesis.

Expression of LGR5 in hepatoma cells, HCC tissue and its significance

Significance of Cathepsin D and Chromogranin A Expression in Human Primary Hepatocellular Carcinomas

Cytoplasmic And/or Nuclear Expression of Β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: a Meta-Analysis.

Alterations of Beta-Catenin and Tcf-4 Instead of Gsk-3 Beta Contribute to Activation of Wnt Pathway in Hepatocellular Carcinoma

Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation